Livzon Mabpharm

company

About

Livzon Mabpharm is a Chinese biotechnology company focused on the development, manufacture, and sale of antibody-based drugs.

  • 501 - 1000

Details

Last Funding Type
Series A
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2010
Number Of Employee
501 - 1000
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Livzon Mabpharm has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jun 27, 2018 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 27, 2018 Series A 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
1
Livzon Mabpharm has made 1 investments. Their most recent investment was on Apr 16, 2014, when Epirus Biopharmaceuticals raised $36M.
Date Company Name
Round Money Raised Industry Lead Investor
Series B $36M Biotechnology Yes

Investors

Number of Lead Investors
Number of Investors
1
Livzon Mabpharm is funded by 1 investors. YFPharmab are the most recent investors.
Investor Name Lead Investor Funding Round
YFPharmab Series A